Skip to content
Disclosery

ORACLE INVESTMENT MANAGEMENT INC

Follow

13F filer, CIK 1012622, GREENWICH, CT

ORACLE INVESTMENT MANAGEMENT INC reported $183,665,090 across 19 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-02-14. Its ten largest share positions make up 99.25% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001085146-25-001704

Period
2024-12-31
Reported value
$184M
Holdings
19
Top 10 weight
99.25%
New
3
Sold out
6

Largest buys vs the previous quarter

SecurityShares changeApprox. value
SPRINGWORKS THERAPEUTICS INCadded+220,573$7.97M
BHVNadded+146,520$5.47M
ARDXadded+720,231$3.65M
PLTRadded+1,000$75.6K
FORAadded+10,000$20.6K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
PHATreduced-604,423-$4.91M
MYGNexited-134,500-$3.68M
WGSreduced-22,300-$1.71M
PACBreduced-448,239-$820K
BIODESIX INCexited-28,916-$51.5K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q4 2024

Share positions as resolved from 13F-HR 0001085146-25-001704, largest first. % of portfolio is the value over $148,941,324, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,126,607 shares; 2024Q2: 1,105,768 shares; 2024Q3: 1,045,768 shares; 2024Q4: 1,023,468 shares 1,023,468$78.7M52.82%-22,300Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 804,850 shares; 2024Q2: 700,450 shares; 2024Q3: 705,250 shares; 2024Q4: 851,770 shares 851,770$31.8M21.36%+146,520Timeline
ARDXARDELYX INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,039,700 shares; 2024Q2: 1,488,131 shares; 2024Q3: 1,369,200 shares; 2024Q4: 2,089,431 shares 2,089,431$10.6M7.11%+720,231Timeline
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 421,583 shares; 2024Q2: 233,200 shares; 2024Q3: 34,200 shares; 2024Q4: 254,773 shares 254,773$9.2M6.18%+220,573
QDELQUIDELORTHO CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 157,201 shares; 2024Q2: 118,291 shares; 2024Q3: 118,291 shares; 2024Q4: 118,291 shares 118,291$5.27M3.54%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 535,558 shares; 2024Q2: 535,558 shares; 2024Q3: 535,558 shares; 2024Q4: 535,558 shares 535,558$4.03M2.7%0Timeline
FORAFORIAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,355,807 shares; 2024Q2: 1,356,107 shares; 2024Q3: 1,356,107 shares; 2024Q4: 1,366,107 shares 1,366,107$2.81M1.89%+10,000Timeline
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: 27,500 shares; 2024Q4: 28,500 shares 28,500$2.16M1.45%+1,000Timeline
CAVACAVA GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 17,600 shares; 2024Q2: 18,600 shares; 2024Q3: 18,600 shares; 2024Q4: 18,600 shares 18,600$2.1M1.41%0Timeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: not reported; 2024Q2: 225,000 shares; 2024Q3: 749,487 shares; 2024Q4: 145,064 shares 145,064$1.18M0.79%-604,423Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 1,356,026 shares; 2024Q2: 423,138 shares; 2024Q3: 727,877 shares; 2024Q4: 279,638 shares 279,638$512K0.34%-448,239Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 2,412 shares; 2024Q2: 2,412 shares; 2024Q3: 2,412 shares; 2024Q4: 2,412 shares 2,412$369K0.25%0Timeline
EYPTEYEPOINT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: 461,857 shares; 2024Q2: 231,857 shares; 2024Q3: 32,500 shares; 2024Q4: 32,500 shares 32,500$242K0.16%0Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
SELECT SECTOR SPDR TRSELECT SECTOR SPDR TR PUTput115,000$15.8Mnew
BIOHAVEN LTDBIOHAVEN LTD COMcall200,000$7.47M-102,700
NOVAVAX INCNOVAVAX INC COM NEWcall466,000$3.75M-68,600
ARDELYX INCARDELYX INC COMcall584,700$2.96M+154,500
TELADOC HEALTH INCTELADOC HEALTH INC OPTIONcall297,700$2.71Mnew
SPRINGWORKS THERAPEUTICS INCSPRINGWORKS THERAPEUTICS INC CALLcall55,800$2.02Mnew

Sold out in Q4 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SPDR SERIES TRUSTSPDR SERIES TRUST100,000$9.88Mcall
MYGNMYRIAD GENETICS INC134,500$3.68Mshares
PHATHOM PHARMACEUTICALS INCPHATHOM PHARMACEUTICALS INC192,700$3.48Mcall
EYEPOINT INCEYEPOINT INC350,000$2.8Mcall
PALANTIR TECHNOLOGIES INCPALANTIR TECHNOLOGIES INC20,000$744Kcall
BIODESIX INCBIODESIX INC28,916$51.5Kshares

How Q4 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001085146-25-001704 base2025-02-14acceptance time not in the bulk data set